Iodixanol (Visipaque) is a new nonionic roentgen contrast medium intended for general use. Visipaque is a pharmaceutical formulation of iodixanol which is isotonic and iso-osmotic with blood. Two synthetic routes from 5-nitro-isophthalic acid to iodixanol are described. The chemical structure is confirmed by spectroscopical data (1H-NMR, 13C-NMR, FAB-MS, electrospray-MS, UV, IR and Raman). Chromatographic characteristics are related to the isomerism of iodixanol.
AarsE. V.EivindvikK.: Formulation, stability and compatibility of iodixanol. Acta Radiol. (1995), Suppl. 399, p. 50.
2.
BergA.FagervollR.: Synthesis, isomerism and characterization of iopentol. Acta Radiol. (1987), Suppl. 370, p. 13.
3.
DugstadH.HeglundI. F.PriebeH.SandeR.TønsethC. P.: Synthesis, analysis and toxicity of three compounds formed during the synthesis of iodixanol. Acta Chem. Scand.49 (1995), 737.
4.
DungD. V.MarienJ.De PauwE.DeCuyperJ.: Secondary ion mass spectrometry of some promazines and photochemistry of chlorpromazine in glycerol. Org. Mass Spectrom.19 (1984), 276.
5.
EdomR. W.Mc KayGHubbardJ. W.MidhaK. K.: Dehalogenation reactions in the fast atom bombardment mass spectrometry of phenothiazine-related drugs. Biol. Mass Spectrom.20 (1991), 585.
6.
EivindvikK.SjøgrenC. E.: Physicochemical properties of iodixanol. Acta Radiol. (1995), Suppl. 399, p. 32.
7.
FossheimR.GulbrandsenT.PriebeH.AasenA. J.: Rotational barriers and the number of stereoisomers of iodixanol (Visipaque®), an X-ray contrast agent. Acta Chem. Scand.49 (1995), 589.
8.
HansenP. E.HoltermannH.WilleK.: X-ray contrast agents. EP 0 108 638 Al, Appl. No. 83306766.3, Int. Cl. C 07 C 103/78, WPI 84-128980/21.
9.
KarlssonJ. O. G.GregersenM.RefsumH.: Effects of Visipaque and Omnipaque on water content of human erythrocytes. Acta Radiol.35 (1994), Suppl. 394, p. 56.
10.
MusserS. M.KelleyJ. A.: Factors affecting dehalogenation reactions of substituted nucleosides in FAB/MS. The 38th ASMS conference on mass spectrometry and allied topics (1990), p. 172.
11.
PriebeH.AukrustA.BjørsvikH. R.TønsethC. P.WiggenU. N.: Stability of the X-ray contrast agent iodixanol = 3,3′,5,5′-tetrakis(2,3-dihydroxypropylcarbamoyl)-2,2′,4,4′,6,6′-hexaiodo-NN′-(2-hydroxypropane-1,3-diyl) -diacetanilide towards acid, base, oxygen, heat and light. Submitted to Drug Stability (1995).
12.
ThébergeR.PaulG. J. C.BertrandM. J.: Systematic study of the effects of experimental parameters on the beam-induced dehalogenation of chlorpromazine in liquid secondary ion mass spectrometry. Org. Mass Spectrom.29 (1994), 18.
